Alina Błaszczyk

418 total citations
22 papers, 339 citations indexed

About

Alina Błaszczyk is a scholar working on Organic Chemistry, Cancer Research and Molecular Biology. According to data from OpenAlex, Alina Błaszczyk has authored 22 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 10 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Alina Błaszczyk's work include Carcinogens and Genotoxicity Assessment (10 papers), Synthesis and Biological Evaluation (9 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Alina Błaszczyk is often cited by papers focused on Carcinogens and Genotoxicity Assessment (10 papers), Synthesis and Biological Evaluation (9 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Alina Błaszczyk collaborates with scholars based in Poland, United States and Denmark. Alina Błaszczyk's co-authors include Janusz Skolimowski, Renata Kontek, Regina Osiecka, Mateusz Fijałkowski, Józef Kula, Andrzej Jóźwiak, Emilia Fornal, Agnieszka Chmiel, PAWEŁ JAŁOSZYŃSKI and Peter Højrup and has published in prestigious journals such as Food Chemistry, Tetrahedron and Toxicology Letters.

In The Last Decade

Alina Błaszczyk

21 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alina Błaszczyk Poland 11 103 70 52 51 47 22 339
William T. Jewell United States 13 54 0.5× 174 2.5× 42 0.8× 53 1.0× 67 1.4× 20 565
Sukeji Suzuki Japan 13 46 0.4× 100 1.4× 17 0.3× 54 1.1× 36 0.8× 33 496
Yoko UEMATSU Japan 10 30 0.3× 111 1.6× 16 0.3× 51 1.0× 64 1.4× 51 443
María Teresa Sumaya-Martínez Mexico 11 98 1.0× 132 1.9× 7 0.1× 21 0.4× 181 3.9× 23 499
Saleh A. Turujman United States 9 72 0.7× 126 1.8× 25 0.5× 6 0.1× 33 0.7× 13 440
Keiko HIRATA Japan 10 60 0.6× 132 1.9× 12 0.2× 23 0.5× 47 1.0× 34 324
Diane Julien-David France 13 38 0.4× 205 2.9× 14 0.3× 14 0.3× 164 3.5× 22 542
Atsuko Tada Japan 13 35 0.3× 145 2.1× 19 0.4× 10 0.2× 104 2.2× 38 442
Vera M. S. Isca Portugal 10 52 0.5× 122 1.7× 7 0.1× 15 0.3× 63 1.3× 28 312
Fatemeh Barzegar Iran 10 24 0.2× 78 1.1× 47 0.9× 9 0.2× 106 2.3× 20 345

Countries citing papers authored by Alina Błaszczyk

Since Specialization
Citations

This map shows the geographic impact of Alina Błaszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alina Błaszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alina Błaszczyk more than expected).

Fields of papers citing papers by Alina Błaszczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alina Błaszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alina Błaszczyk. The network helps show where Alina Błaszczyk may publish in the future.

Co-authorship network of co-authors of Alina Błaszczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Alina Błaszczyk. A scholar is included among the top collaborators of Alina Błaszczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alina Błaszczyk. Alina Błaszczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Błaszczyk, Alina, et al.. (2025). Host cell protein quantitation by LC-MS. Experimental demonstration, qualification, and comparison of methods in USP 1132.1. Journal of Pharmaceutical and Biomedical Analysis. 265. 117051–117051. 1 indexed citations
2.
Błaszczyk, Alina, et al.. (2020). Cytotoxic and genotoxic effects of (R)‐ and (S)‐ricinoleic acid derivatives. Chirality. 32(7). 998–1007. 7 indexed citations
3.
Kula, Józef, et al.. (2019). Chiral amide derivatives of ricinoleic acid and 3-hydroxynonanoic acid synthesis and cytotoxic activity. Medicinal Chemistry Research. 28(7). 948–958. 3 indexed citations
4.
Błaszczyk, Alina, et al.. (2018). Wpływ programu 500 plus na ewolucję demograficzną polskiego społeczeństwa. University of Lodz Repository (University of Łódź). 53(4). 7–25. 1 indexed citations
5.
Chmiel, Agnieszka, et al.. (2017). Synthesis and cytotoxicity of (R)‐ and (S)‐ricinoleic acid amides and their acetates. Chirality. 29(10). 616–622. 7 indexed citations
6.
Fijałkowski, Mateusz, et al.. (2016). Studies on the cytotoxicity of diamond nanoparticles against human cancer cells and lymphocytes. Chemico-Biological Interactions. 254. 156–166. 27 indexed citations
9.
Skolimowski, Janusz, et al.. (2013). Cytotoxicity of nitroxyl (HNO/NO−) against normal and cancer human cells. Chemico-Biological Interactions. 206(2). 262–271. 12 indexed citations
10.
Błaszczyk, Alina, et al.. (2013). Ethoxyquin: An Antioxidant Used in Animal Feed. International Journal of Food Science. 2013. 1–12. 102 indexed citations
11.
Skolimowski, Janusz, et al.. (2010). Modulation of ethoxyquin genotoxicity by free radical scavengers and DNA damage repair in human lymphocytes. Toxicology Letters. 193(2). 194–199. 7 indexed citations
12.
Błaszczyk, Alina & Janusz Skolimowski. (2007). Preparation of ethoxyquin salts and their genotoxic and antioxidant effects on human lymphocytes. ARKIVOC. 2007(6). 217–229. 2 indexed citations
13.
Błaszczyk, Alina & Janusz Skolimowski. (2007). Evaluation of the genotoxic and antioxidant effects of two novel feed additives (ethoxyquin complexes with flavonoids) by the comet assay and micronucleus test. Food Additives & Contaminants. 24(6). 553–560. 5 indexed citations
14.
Błaszczyk, Alina & Janusz Skolimowski. (2006). Comparative analysis of cytotoxic, genotoxic and antioxidant effects of 2,2,4,7-tetramethyl-1,2,3,4-tetrahydroquinoline and ethoxyquin on human lymphocytes. Chemico-Biological Interactions. 162(1). 70–80. 25 indexed citations
15.
Błaszczyk, Alina & Janusz Skolimowski. (2006). Synthesis and studies on antioxidants: ethoxyquin (EQ) and its derivatives.. PubMed. 62(2). 111–5. 10 indexed citations
16.
Błaszczyk, Alina, et al.. (2006). Genotoxic and antioxidant activities of ethoxyquin salts evaluated by the comet assay. Chemico-Biological Interactions. 162(3). 268–273. 10 indexed citations
17.
Błaszczyk, Alina & Janusz Skolimowski. (2005). Apoptosis and cytotoxicity caused by ethoxyquin and two of its salts.. PubMed. 10(1). 15–21. 24 indexed citations
18.
Błaszczyk, Alina. (2005). DNA damage induced by ethoxyquin in human peripheral lymphocytes. Toxicology Letters. 163(1). 77–83. 25 indexed citations
19.
Błaszczyk, Alina, Regina Osiecka, & Janusz Skolimowski. (2003). Induction of chromosome aberrations in cultured human lymphocytes treated with ethoxyquin. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 542(1-2). 117–128. 22 indexed citations
20.
Błasiak, Janusz, Andrzej Trzeciak, PAWEŁ JAŁOSZYŃSKI, et al.. (1997). DNA breaking activity of the pesticide malathion and its metabolite assayed by the single cell gel electrophoresis [comet assay]. Cellular & Molecular Biology Letters. 2(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026